Author:
Donato Dominique M.,Hanks Steven K.
Publisher
Springer International Publishing
Reference20 articles.
1. Brabek J, Constancio SS, Siesser PF, Shin NY, Pozzi A, Hanks SK. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol Cancer Res. 2005;3:307–15.
2. Chodniewicz D, Klemke RL. Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold. Biochim Biophys Acta. 2004;1692:63–76.
3. Cowell LN, Graham JD, Bouton AH, Clarke CL, O’neill GM. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway. Oncogene. 2006;25:7597–607.
4. Cunningham-Edmondson AC, Hanks SK. P130Cas substrate domain signaling promotes growth, migration, and invasion of estrogen-receptor-negative breast cancer cells. Breast Cancer Targets Ther. 2009;1:39–52.
5. Defillipi P, Di Stefano P, Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol. 2006;16:257–63.